Search
XORTX Therapeutics Inc
XRTXAdd to Watchlist
2.270USD
+0.070+3.18%
Close 06/30, 16:00（ET）Quotes delayed by 15 min
3.64MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
1
analysts
Buy
Current Rating
70.000
Target Price
+2943.48%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
561
Total
5
Median
6
Average
Company name
Ratings
Analysts
XORTX Therapeutics Inc
XRTX
1
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is XORTX Therapeutics Inc's price target?
Analysts forecast that XORTX Therapeutics Inc's price target is USD 14.00, with the highest forecast at USD 14.00 and the lowest forecast at USD 14.00.
What is the analyst rating for XORTX Therapeutics Inc?
Based on the ratings of XORTX Therapeutics Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
